Position in AVXL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$154,017
-$47,253 QoQ
Shares Held
50,169
-11.3% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. AVXL ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in AVXL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $154,017 | 50,169 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $201,270 | 56,537 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $401,076 | 45,065 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $453,051 | 49,138 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $416,746 | 48,572 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $438,437 | 40,823 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $241,767 | 42,565 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $174,598 | 41,374 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $243,856 | 47,909 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $599,898 | 64,436 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $419,748 | 64,084 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $481,994 | 59,286 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $494,676 | 57,722 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $407,197 | 43,974 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $451,199 | 43,721 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $407,355 | 40,695 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $510,617 | 41,480 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $578,096 | 33,339 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $441,533 | 24,598 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $762,676 | 33,363 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $333,832 | 22,330 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $338,871 | 62,754 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $89,629 | 19,699 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $206,067 | 41,884 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $43,296 | 13,745 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||